Sevoflurane Decreases the Risk of Postoperative Delirium After Cerebral Hypoxemia During Surgery

NCT ID: NCT02133638

Last Updated: 2014-05-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

PHASE4

Total Enrollment

130 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-05-31

Study Completion Date

2015-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this study is to distinguish possible differences in frequency of delirium after Volatile Induction and Maintenance of Anesthesia and Total Intravenous Anesthesia in case of undeliberate cerebral desaturation during non-cardiac surgery.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The aim of the present study is to investigate whether in non-cardiac surgery the frequency of POD after intraoperative undeliberate cerebral saturation could be modulated by the choice of the anesthetic strategy (Volatile Induction and Maintenance of Anesthesia \[VIMA\] and Total Intravenous Anesthesia \[TIVA\]). Based on our previous data we hypothesized that incidence of POD would be lower with VIMA compared to TIVA.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cerebral Hypoxia Postoperative Delirium

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Sevoflurane

Sevoflurane Based Volatile Induction and Maintenance of Anaesthesia

Group Type ACTIVE_COMPARATOR

Sevoflurane

Intervention Type DRUG

Induction of anesthesia: fentanyl 2 µg kg-1 and a bolus inhalation of 8% sevoflurane in an 8 L.min-1 fresh gas flow. Anesthesia maintenance: 1 minimal alveolar concentration (MAC) sevoflurane at a low fresh gas flow of 0.6-0.8 L min-1 in a 60% air-oxygen mixture supplemented with boluses of fentanyl.

Propofol

Propofol Based Total Intravenous Anesthesia

Group Type ACTIVE_COMPARATOR

Propofol

Intervention Type DRUG

Induction of anesthesia: propofol 2 mg kg-1 and fentanyl 4 µg kg-1. Maintenance of anesthesia: infusion of propofol 8 mg kg-1 h-1 and boluses of fentanyl 3 µg kg-1.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Sevoflurane

Induction of anesthesia: fentanyl 2 µg kg-1 and a bolus inhalation of 8% sevoflurane in an 8 L.min-1 fresh gas flow. Anesthesia maintenance: 1 minimal alveolar concentration (MAC) sevoflurane at a low fresh gas flow of 0.6-0.8 L min-1 in a 60% air-oxygen mixture supplemented with boluses of fentanyl.

Intervention Type DRUG

Propofol

Induction of anesthesia: propofol 2 mg kg-1 and fentanyl 4 µg kg-1. Maintenance of anesthesia: infusion of propofol 8 mg kg-1 h-1 and boluses of fentanyl 3 µg kg-1.

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Sevorane Ultane Fluoromethyl hexafluoroisopropyl ether Diprivan Lipuro Propolipid Propoven Recofol Unifol

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* class III-IV by physical status classification system of American Society of Anesthesiologist (ASA)
* history of arterial vascular disease (arterial hypertension, myocardial ischemia and/or cerebral vascular disease)
* undergoing elective non-cardiac surgery (hemicolectomy, hernioplasty, laparoscopic cholecystectomy and laparoscopic hysterectomy)

Exclusion Criteria

* dementia
* stroke or myocardial infarction ≤ 6 months before surgery
* oncological disease of T2-4N3M1 stage
Minimum Eligible Age

65 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Negovsky Reanimatology Research Institute

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Valery V. Likhvantsev, MD, Prof.

Role: STUDY_CHAIR

Negovsky Reanimatology Research Institute, Moscow, Russia

Oleg A. Grebenchikov, MD, PhD

Role: STUDY_DIRECTOR

Negovsky Reanimatology Research Institute, Moscow, Russia

Yuri V. Iljin

Role: PRINCIPAL_INVESTIGATOR

Negovsky Reanimatology Research Institute, Moscow, Russia

Alexander V. Mironenko, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

Negovsky Reanimatology Research Institute, Moscow, Russia

Yuri V. Skripkin

Role: PRINCIPAL_INVESTIGATOR

Negovsky Reanimatology Research Institute, Moscow, Russia

Dmitriy B. Selivanov, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

Hospital Maria Vittoria, Turin, Italy

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Medical center of the Main Administration for Service to the Diplomatic Corps

Moscow, , Russia

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Russia

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Valery V. Likhvantsev, MD, Prof.

Role: CONTACT

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Yuri V. Skripkin

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

s100b

Identifier Type: OTHER

Identifier Source: secondary_id

Sev003

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Optimization of Desflurane in Elderly Patients
NCT01700907 COMPLETED PHASE1/PHASE2
Sevoflurane in Cardiac Surgery
NCT00821262 COMPLETED PHASE4
Sevoflurane, Propofol, Postoperative Pain
NCT01437462 COMPLETED PHASE4